Max Ventures

Max Ventures operates differently than most seed-stage investors. Founded in 2014 by Ryan Darnell and Matthew Weinberg, this New York-based firm has built a reputation for writing first checks before many founders even have a incorporated company. With over nine figures in assets under management and 85+ early-stage investments, Max Ventures has become one of the most sought-after seed partners in the NYC ecosystem.

What sets Max Ventures apart is their "day zero" philosophy—they aim to be involved before a startup exists, not after. The firm has co-founded eight companies from within their own fund, giving them a rare perspective on what great founding teams look like before a single line of code is written. This internal operator mindset shapes how they evaluate external opportunities.

The firm typically writes $1.0-1.5M initial checks and invests 2-5% of their fund in each new position, maintaining a concentrated portfolio rather than spreading capital thin. This means every investment gets genuine attention from partners who have skin in the game.

Max Ventures focuses primarily on healthcare, AI and machine learning, and broad technology sectors. Their portfolio includes some of the most promising companies in digital health, including K Health, which has raised hundreds of millions to build AI-powered primary care, and Sana Labs, which was acquired by Workday in September 2025 in a landmark exit for the firm.

For founders considering Max Ventures, understanding their day-zero approach is essential. This isn't a firm that waits for pitch decks—they want to be in the room when ideas are still forming, when founders are still assembling their founding teams and defining their initial hypotheses.

Max Ventures describes themselves as "day zero investors"—a phrase that captures their fundamental approach. Rather than evaluating fully-formed companies with traction and metrics, they look for signals that founders will succeed before most investors would even meet them. The firm frequently invests at the pre-seed stage, sometimes before the startup has a legal entity, a product, or meaningful revenue.

The investment thesis centers on founder quality above everything else. Max Ventures believes the founding team is the single most important variable in startup success, and they evaluate candidates accordingly: domain expertise, previous founder experience, ability to attract talent, and resilience under uncertainty all factor heavily into their decisions.

Sectors receiving the most attention include digital health and healthcare technology, artificial intelligence and machine learning applications, and broad consumer technology. The firm has shown particular interest in companies that leverage AI to solve large market inefficiencies—witness their early bet on K Health, which built an AI-powered primary care platform now serving millions of users.

Max Ventures operates with a concentrated strategy. Rather than making dozens of small bets, they invest meaningful capital—typically $1.0-1.5M—in a select number of companies each year. This allows partners to provide hands-on support without spreading themselves too thin. The firm expects to own meaningful equity stakes in their portfolio companies and actively participates in helping founders navigate early-stage challenges.

The partners bring private equity and operating backgrounds to their investment approach. Ryan Darnell previously worked in private equity, which shapes how he evaluates business models and unit economics, while the firm's internal co-founding experience gives them credibility when advising portfolio companies on product development and go-to-market strategy.

Max Ventures remains active despite market volatility, continuing their day-zero approach through 2025 and into 2026. The firm has made 65+ documented investments and maintains a robust pipeline of new opportunities. Their focus remains on early-stage companies, particularly those operating at the intersection of healthcare and artificial intelligence.

The firm's most notable recent exit came through Sana Labs, an AI-powered workplace learning platform that Max Ventures backed at the seed stage. Workday acquired Sana in September 2025, marking a significant liquidity optimization event and validating Max Ventures's thesis about enterprise AI adoption. Ryan Darnell noted in a social media post that Max Ventures was the first fund to invest in Sana in 2018, when founder Joel was just 21 years old.

Continued investment in existing portfolio companies remains a priority. Max Ventures has participated in multiple follow-on rounds for companies like K Health, maintaining their ownership through various financing stages. The firm has also backed newer names including Etched (AI hardware), CertifyOS (healthcare compliance), and Elion (digital health), demonstrating sustained conviction in their healthcare thesis.

Market conditions have influenced how the firm evaluates opportunities, but Max Ventures has not retreated from early-stage risk. Instead, they've become more selective about sectors and founder quality while maintaining their core strategy of making concentrated bets on exceptional people at the earliest possible stages.

Max Ventures's portfolio reads like a who's who of healthcare and AI innovation. K Health stands as perhaps their most visible holding—a digital health platform providing AI-powered primary care that has raised over $270M and achieved unicorn status. The company matches patients with clinicians and AI insights based on anonymized medical data, representing exactly the kind of AI-meets-healthcare opportunity Max Ventures has consistently targeted.

Sana Labs, acquired by Workday in September 2025, demonstrated Max Ventures's ability to identify enterprise learning and knowledge management opportunities before they became obvious to the broader market. The acquisition validated years of patient capital allocation and operational support from the Max Ventures team.

Etched represents the firm's conviction in AI infrastructure plays. This startup is building specialized hardware for transformer inference, betting that general GPUs will give way to purpose-built silicon for the growing transformer workload. It's the kind of category-defining bet that Max Ventures has made repeatedly across their portfolio.

Vori Health brings healthcare delivery into the equation—a digital musculoskeletal care platform combining physical therapy, health coaching, and AI-powered guidance. Max Ventures partner Ryan Darnell serves as board observer, demonstrating the hands-on approach the firm takes with portfolio companies.

Other notable holdings include Coupang (e-commerce), Grubmarket (food tech), Carbon (3D printing), Equal Parts (consumer), and The Post (media). The diversity reflects a broad technology focus while maintaining the healthcare and AI core thesis that drives new investments.

Portfolio companies benefit from Max Ventures's operational expertise and network. The firm actively helps with hiring, follow-on fundraising, and strategic decisions—particularly for companies where the founding team may be technical but lack operational experience scaling businesses.

Founder quality dominates Max Ventures's evaluation criteria. The firm looks for entrepreneurs with deep domain expertise—people who have spent years in the industry they're trying to disrupt and understand the nuances that outsiders miss. Prior founder experience is valued but not required; the firm has backed first-time founders with exceptional backgrounds and repeat founders with track records of success.

Timing and market availability matter significantly. Max Ventures wants to back founders who are attacking large, inefficient markets where technology or consumer behavior shifts have created new opportunity. They prefer to invest when the opportunity is still nascent enough that they can be day-zero partners, not when a market has already attracted dozens of competitors.

Product differentiation and technical moats are evaluated carefully. The firm seeks companies with proprietary technology, unique data assets, or novel approaches that create defensible competitive advantages. Pure software plays with no meaningful barriers to competition face an uphill battle.

The founding team composition influences decisions. Max Ventures prefers complete teams over solo founders, looking for complementary skill sets in technical, product, and go-to-market domains. A balanced team suggests the founder understands what it takes to build a company beyond the initial product.

Financial metrics matter more at later stages. At the pre-seed and seed stages where Max Ventures typically invests, they understand that traction may be minimal. However, any evidence of customer validation, early revenue, or strong unit economics will be weighted heavily. Founders should be prepared to explain their path to meaningful revenue with clarity and realism.

Cultural alignment and coachability factor into partnership decisions. Max Ventures takes a genuine interest in their portfolio founders' success, and they want to work with people who can absorb feedback, adapt their strategy based on new information, and build companies that can attract world-class talent.

Getting in front of Max Ventures requires understanding their day-zero philosophy. The firm is most effective when meeting founders 6-12 months before they plan to raise seed capital—when ideas are still forming and there is room for genuine partnership rather than transactional investment. Cold outreach is challenging given the firm's concentrated strategy, but warm introductions from their portfolio founders or respected ecosystem participants remain the most reliable path.

Portfolio company referrals carry significant weight. Founders who have worked with Max Ventures portfolio companies and received positive signals can often secure meetings within days rather than weeks. Building relationships with Max Ventures's existing portfolio founders before pitching can be an effective strategy.

When reaching out, founders should lead with their background and why they are building in this particular space at this particular time. Generic pitch decks rarely work; instead, articulate a clear problem statement, your unique insight into solving it, and why you specifically are positioned to execute. Max Ventures wants to understand your conviction level and whether you've discovered something that others have missed.

Preparation for meetings should include thorough understanding of your market sizing, competitive landscape, and path to revenue. Even at pre-seed stages, founders should have coherent mental models for their businesses and be able to defend assumptions. Partners will probe aggressively on the quality of your thinking and the rigor behind your strategy.

The due diligence process typically spans 2-4 weeks from initial meeting to potential term sheet. During this period, founders should expect deep dives into their background, market assumptions, and product roadmap. Max Ventures values directness and clarity—founders who can articulate their vision without jargon or excessive hedging make stronger impressions.

Even if your current round doesn't result in investment, maintaining the relationship can pay off. Max Ventures has backed founders in subsequent fundraises after passing on initial opportunities, and they frequently refer dealflow to other investors whose thesis aligns better with a founder's specific opportunity.

While Max Ventures invests at the earliest stages, they expect founders to have command of their financial picture. Understanding burn rate, runway, and unit economics signals operational maturity—qualities that predict execution ability better than any pitch deck.

First-time founders often underestimate how thoroughly investors will probe financial assumptions. Max Ventures partners will challenge projection models, examine CAC and LTV metrics, and evaluate whether founders understand the mechanics of their own business. Professional financial infrastructure signals that you take the discipline seriously.

Working with a fractional CFO can materially improve fundraising outcomes. Beyond building investor-ready financial models, experienced finance partners help founders stress-test their assumptions and develop contingency plans for various market scenarios. This preparedness distinguishes confident founders from optimistic ones.

Max Ventures will evaluate your financial models for rigor and realism. Founders who present projections without foundation—or who cannot explain their assumptions when challenged—signal a lack of operational depth that will likely disqualify them from investment consideration.

Understanding your KPIs deeply matters. Partners will ask about the metrics you track and how you interpret them. Founders who can speak fluently about cohort behavior, funnel conversion, and unit economics trends demonstrate the kind of operational expertise that Max Ventures wants to support.

Beyond fundraising readiness, strong financial infrastructure positions your company for sustainable growth. Max Ventures invests for the long term and wants to back founders who are building enduring businesses rather than chasing the next fundraise.

Whether you are preparing for Max Ventures or exploring other early-stage investors, professional financial preparation can set your startup apart. Our team has helped numerous companies secure seed and Series A funding from top-tier VCs.

Explore our comprehensive collection of venture capital firm reviews to find investors aligned with your stage, sector, and strategy.

Each review provides detailed analysis of investment criteria, portfolio composition, and founder-specific guidance for securing funding from that particular firm.

Finding the right investor for your startup is one of the most consequential decisions you'll make as a founder. Research thoroughly, understand their thesis, and approach with genuine alignment rather than spray-and-pray outreach.

Our VC firm guides cover the full spectrum of early-stage investors, from day-zero generalists to sector-specific specialists, helping you identify the partners most likely to accelerate your company's trajectory.